| 1. We will conduct and promote our work on Sc2.0 for the benefit of humankind. |
| 2. We will participate with the project’s efforts to engage with the public and be transparent and open about our work on Sc2.0. |
| Intellectual property |
| 3. Intellectual property rights will not be taken on Sc2.0 once created, nor on the intermediary clones and strains generated as part of the project. |
| 4. Data and materials generated by this project will be made available to other researchers. |
| Safety |
| 5. All sequence providers generating sequences for use in Sc2.0 shall be in compliance with the U.S. Department of Health and Human Services’ Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA. |
| 6. Members of the Sc2.0 Project will assess individuals requesting Sc2.0 Project data/materials prior to shipment of any such materials to help reduce the chance that we are distributing materials to those with nefarious intent. |
| 7. Our laboratories, practices, and methods will have at their core an ethos of safety for both laboratory workers and the communities outside our institutions. |
| 8. All personnel will receive training in biosafety, dual-use concerns, and other ethics issues, as appropriate. |
| 9. Our work on Sc2.0 is in compliance with national and local laws. |
| Governance |
| 10. The Sc2.0 Executive Committee will address any issues that may arise with regard to safety or compliance with this agreement. |
| 11. We will revisit this agreement as the project and the technologies it uses develop to ensure that any risk posed by this work is appropriately matched to the oversight it receives. |
